Pre-order Enquiry
Request Free Sample
Global Guaifenesin (API) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13856675 | Publishing Date : 15-Feb-2019 | No. of pages : 118
Request Sample
Request Customization
Check Discounts
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Scope of the Report:
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The worldwide market for Guaifenesin (API) is expected to grow at a CAGR of roughly 0.6% over the next five years, will reach 58 million US$ in 2024, from 56 million US$ in 2019, according to a new study.
This report focuses on the Guaifenesin (API) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
98%-99%
>99%
Market Segment by Applications, can be divided into
Pharmaceuticals
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Guaifenesin (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Guaifenesin (API), with price, sales, revenue and global market share of Guaifenesin (API) in 2017 and 2018.
Chapter 3, the Guaifenesin (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Guaifenesin (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Guaifenesin (API) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Guaifenesin (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The worldwide market for Guaifenesin (API) is expected to grow at a CAGR of roughly 0.6% over the next five years, will reach 58 million US$ in 2024, from 56 million US$ in 2019, according to a new study.
This report focuses on the Guaifenesin (API) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
98%-99%
>99%
Market Segment by Applications, can be divided into
Pharmaceuticals
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Guaifenesin (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Guaifenesin (API), with price, sales, revenue and global market share of Guaifenesin (API) in 2017 and 2018.
Chapter 3, the Guaifenesin (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Guaifenesin (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Guaifenesin (API) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Guaifenesin (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
